Conflict of Interest: C.-H. Tang is a member of the governing board of the Taiwan Society for Pharmacoeconomics and Outcome Research. She received honoraria from Janssen-Cilag Taiwan and GlaxoSmithKline Taiwan. She also received research grants from Janssen-Cilag Taiwan, GlaxoSmithKline Taiwan; Merck Taiwan, and Allergan Singapore Pte Ltd. Y.-C. Chen has no conflict of interest. K. Ng is employed as Regional Market Access Director (Asia Pacific) by Allergan Singapore Pte Ltd. S.-J. Wang is a member of the governing board of the Taiwan Headache Society. He has received consulting fees or honoraria from Allergan, Eli Lilly and Company (Taiwan), Merck Sharp & Dohme (Taiwan), and Pfizer; payments for lectures or service on speaker bureaus from Allergan, Eli Lilly and Company, and Boehringer Ingelheim Taiwan; and has been awarded grants from Allergan and Wyeth.
A Retrospective Matched Case–Control Study on Medical Costs of Refractory Migraine in Taiwan
Article first published online: 13 FEB 2013
© 2013 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 53, Issue 3, pages 526–539, March 2013
How to Cite
Tang, C.-H., Chen, Y.-C., Ng, K. and Wang, S.-J. (2013), A Retrospective Matched Case–Control Study on Medical Costs of Refractory Migraine in Taiwan. Headache: The Journal of Head and Face Pain, 53: 526–539. doi: 10.1111/head.12039
- Issue published online: 13 MAR 2013
- Article first published online: 13 FEB 2013
- Manuscript Accepted: 3 DEC 2012
- Allergan Singapore Pte Ltd
Appendix S1 SAS codes and regression results for total costs prediction in Table 2.
Appendix S2 SAS codes and regression results for total costs prediction in Table 3.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.